Metagenomi Therapeutics, Inc. - Common stock, par value $0.0001 per share (MGX)

Q: What does CUSIP 59102M104 represent in this 13F holders report?

CUSIP 59102M104 is the security identifier for MGX - Metagenomi Therapeutics, Inc. - Common stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held MGX - Metagenomi Therapeutics, Inc. - Common stock, par value $0.0001 per share in Q4 2025?

54 institutional investors reported MGX - Metagenomi Therapeutics, Inc. - Common stock, par value $0.0001 per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 59102M104

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class: Equity / Common stock, par value $0.0001 per share
Total 13F shares: 6,764,212
Total 13F value: $10,956,656
Share change: +1,372,995
SEC-reported price per share: $1.62
Number of holders: 54
Value change: +$2,099,977
Number of buys: 24
Number of sells: 25
Shares outstanding: 37,837,562

Security key

59102M104

Report period

Q4 2025

Institutions

Top holders

MGX full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Metagenomi Therapeutics, Inc. SEC filings Metagenomi Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 59102M104

Newer quarter: Q1 2026 Previous quarter: Q3 2025

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of MGX - Metagenomi Therapeutics, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BAYER HEALTHCARE LLC

Disclosed value leader

BAYER HEALTHCARE LLC

Comparable rows

0/15

Latest evidence

05 Dec 2025

3/4/5 13F Highest disclosed value: $11,666,871 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BAYER HEALTHCARE LLC has the largest disclosed position value at $11.67M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAYER HEALTHCARE LLC's linked filing trail.

Disclosed position value Top 5

BAYER HEALTHCARE LLC $11.67M

Novo Holdings A/S $5.01M

Sebastian Bernales $6.62M

Thomas Brian C. $4.45M

VANGUARD GROUP INC $2.94M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BAYER HEALTHCARE LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$11,666,871 4,050,997 shares	—	13 Feb 2024
Novo Holdings A/S	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$5,008,824 1,739,175 shares	—	09 Feb 2024
Sebastian Bernales	3/4/5 Director 3/4/5	— mixed-class rows	$6,620,950 3,147,422 shares mixed-class rows	—	01 Apr 2024
Thomas Brian C.	3/4/5 Director 3/4/5	— mixed-class rows	$4,449,170 2,706,960 shares mixed-class rows	-$6,786	05 Dec 2025
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$2,942,378 1,241,510 shares	—	30 Sep 2025
Sozo Ventures GP II, L.P.	13F Company 13F	— denominator unverified	$1,331,404 581,577 shares	—	30 Sep 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

6,764,212

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

-3

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 value	Q4 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend